secwatch.observer — SEC 8-K summary
======================================

Issuer:     InspireMD, Inc. (NSPR)
CIK:        0001433607
Form:       8-K
Filed at:   2024-04-02T23:59:59+00:00
Accession:  0001493152-24-012648
Event type: other
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InspireMD amends CEO and CFO employment agreements to enhance change-in-control severance
--------------------------------------------------------------------------------

- CEO Marvin Slosman receives 24-month base salary severance plus 2x performance bonus on change-in-control termination.
- CFO Craig Shore receives 12-month base salary severance plus 1x annual bonus on change-in-control termination.
- Both executives get extended option exercise periods (CEO 2 years, CFO 1 year) and up to 24-month (CEO) or 12-month (CFO) benefit continuation.
- Amendments effective April 1, 2024; triggered by termination within 3 months before or 12 months after a change in control.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1433607/000149315224012648/0001493152-24-012648-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1433607/000149315224012648/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-012648

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer